Gender differences in NSAID use among older adults with osteoarthritis

被引:28
作者
Dominick, KL
Ahern, FM
Gold, CH
Heller, DA
机构
[1] Vet Affairs Med Ctr, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA
[4] First Hlth Serv Corp, Harrisburg, PA USA
关键词
gender; geriatrics; nonsteroidal antiinflammatory drugs; osteoarthritis;
D O I
10.1345/aph.1C418
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Nonsteroidal antiinflammatory drugs (NSAIDs) are the most commonly prescribed medications for the treatment of osteoarthritis (OA). Little is known about whether there are important gender differences in NSAID use among patients with OA. OBJECTIVE: To examine gender differences in patterns of NSAID use among older adults (greater than or equal to65 y) with OA. METHODS: Subjects (n = 11298) were members of a statewide prescription drug plan who responded to a health-related quality-of-life (HRQOL) survey in 1997 and had a physician diagnosis of OA. Gender differences in patterns of NSAID use were examined over a 2-year period. RESULTS: Approximately one-third of the participants filled at least 1 NSAID prescription during the study. Women were significantly more likely to be prescribed an NSAID than men (37% vs. 30%), had a greater total days' supply of NSAIDs, and were more frequently prescribed NSAIDs with greater degrees of cyclooxygenase-2 selectivity. These gender differences persisted in statistical analyses controlling for demographic factors, HRQOL, and gastrointestinal (GI) risk factors. CONCLUSIONS: Results of this study showed significant gender differences in patterns of NSAID use, and these differences were independent of the risk for GI adverse effects and self-reported symptoms. Further research is needed to examine reasons for these gender variations, as well as their impact on the quality of symptom management.
引用
收藏
页码:1566 / 1571
页数:6
相关论文
共 25 条
[1]  
Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905
[2]  
American Pain Society, 2002, GUID MAN PAIN OST RH
[3]  
[Anonymous], POPULATION PROJECTIO
[4]  
Ausiello JC, 2002, J RHEUMATOL, V29, P999
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]   USE OF MEDICATIONS BY PERSONS 65 AND OVER - DATA FROM THE ESTABLISHED POPULATIONS FOR EPIDEMIOLOGIC STUDIES OF THE ELDERLY [J].
CHRISCHILLES, EA ;
FOLEY, DJ ;
WALLACE, RB ;
LEMKE, JH ;
SEMLA, TP ;
HANLON, JT ;
GLYNN, RJ ;
OSTFELD, AM ;
GURALNIK, JM .
JOURNALS OF GERONTOLOGY, 1992, 47 (05) :M137-M144
[7]   Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs [J].
Cryer, B ;
Feldman, M .
AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05) :413-421
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]  
Fowles J B, 1995, Health Care Financ Rev, V16, P189
[10]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796